M&A

Gilead can now attempt at takeover of Galapagos
GoinPharma
Sat, 12/1/18 - 12:22 pm
Gilead Sciences
Galapagos
M&A
M&A trends in 2019: Will the biotech bubble burst?
Biopharma Dive
Fri, 11/30/18 - 12:29 pm
M&A
Takeda could rack up $10B in selloffs after controversial Shire buyout: report
Fierce Pharma
Fri, 11/30/18 - 12:22 pm
Takeda
Shire
M&A
shareholders
CVS Health CEO Larry Merlo Says Completed Purchase Of Aetna Will Create 'A New Healthcare Model'
Forbes
Thu, 11/29/18 - 11:16 am
CVS Health
Aetna
insurers
consumers
Healthcare
M&A
Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset
BioSpace
Wed, 11/28/18 - 11:51 am
M&A
Coeptis Pharmaceuticals
Elto Pharma
Amarantus BioSciences
Parkinson's Disease
CVS-Aetna megamerger finalized
Healthcare Dive
Wed, 11/28/18 - 11:48 am
M&A
CVS Health
Aetna
PBMs
insurers
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Xconomy
Tue, 11/27/18 - 11:41 pm
Roche
Jecure Therapeutics
M&A
NASH
Genentech
In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
Endpoints
Tue, 11/27/18 - 11:29 pm
biotech
reverse merger
M&A
Arsanis
X4 Pharma
After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
Xconomy
Mon, 11/26/18 - 10:04 am
Edge Therapeutics
head injury
clinical trials
M&A
PDS Biotechnology
immuno-oncology
Walgreens, Humana Partnership Could Escalate To Investment Stakes
Forbes
Tue, 11/20/18 - 08:29 pm
Walgreens Boots Alliance
Humana
M&A
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Tue, 11/20/18 - 12:17 pm
Takeda
shareholders
Japan
M&A
Shire
Europe
Boston Scientific offers $4B for BTG
Mass Device
Tue, 11/20/18 - 09:52 am
Boston Scientific
M&A
BTG
devices
Are Gilead or Roche Interested in Buying Tesaro? Company Rumored to be on the Market
BioSpace
Mon, 11/19/18 - 11:25 am
Tesaro
Roche
Gilead Sciences
M&A
Grünenthal Snaps up Averitas Pharma for Undisclosed Sum to Extend Presence in the U.S.
BioSpace
Sun, 11/18/18 - 12:43 pm
Grunenthal
Germany
M&A
Averitas Pharma
AstraZeneca
Tesaro stock rebounds on takeout report
BioCentury
Sat, 11/17/18 - 12:53 pm
Tesaro
M&A
Takeda investors mount last-minute effort to stymie Shire deal: FT
Fierce Pharma
Fri, 11/16/18 - 07:50 pm
Takeda
Shire
shareholders
M&A
With the $62B Shire buyout on track, Takeda plans to debut the newly merged company at JPMorgan
Endpoints
Mon, 11/12/18 - 11:39 am
Takeda
Shire
M&A
Christophe Weber
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Sat, 11/10/18 - 12:40 pm
Takeda
Shire
M&A
Europe
Takeda CEO confident about Shire merger
Pharmaforum
Thu, 11/8/18 - 09:44 am
Takeda
Shire
M&A
shareholders
Pharma CEOs
Christophe Weber
CVS Says Aetna Deal Will Close By Thanksgiving
Forbes
Tue, 11/6/18 - 09:36 am
CVS Health
Aetna
M&A

Pages